Coagulation Analyzers - Medical Devices Pipeline Assessment, 2018
July 2018
121
About the Report
About the Report
Coagulation Analyzers-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Coagulation Analyzers-Medical Devices Pipeline Assessment, 2018" provides an overview of Coagulation Analyzers currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coagulation Analyzers pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coagulation Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coagulation Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coagulation Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Products
Products
Analyticon Biotechnologies AG, Coagulyzer 1; Analyticon Biotechnologies AG, Coagulyzer 100; Analyticon Biotechnologies AG, Coagulyzer 2; Analyticon Biotechnologies AG, Coagulyzer 4; BioMedica USA LLC (Inactive), Portable Diagnostic System - Hemostasis; Braun Biosystems, Inc., Bio6; Hansjorg Wyss Institute for Biologically Inspired Engineering, Hemostasis Monitoring Microfluidic Device; Helena Laboratories Corp, Cascade Abrazo Analyzer; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Chronic Liver Disease; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Intensive Care; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Neurosurgery; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Oral Contraception; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Orthopedic Surgery; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Perinatal Care; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer - Trauma; HemoSonics, LLC, HemoSonics Global Hemostasis Analyzer HS-GHA; HemoSonics, LLC, Quantra Hemostasis Analyzer; Nexus Medical, LLC, ProTime InRhythm; SonoMedix, Inc., NanoAcoustic Blood Analyzer; Universal Biosensors Inc, Handheld POC Coagulation Testing System - Ambulatory Care; University of Michigan, mHemoRetractoMeter; University of Texas Health Science Center at Houston, MEMS Based Blood Coagulometer
Companies
Analyticon Biotechnologies AG
BioMedica USA LLC
Braun Biosystems, Inc.
Hansjorg Wyss Institute for Biologically Inspired Engineering
Helena Laboratories Corp
HemoSonics, LLC
Nexus Medical, LLC
SonoMedix, Inc.
Universal Biosensors Inc
University of Michigan
University of Texas Health Science Center at Houston
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Coagulation Analyzers Overview 6
3 Products under Development 7
3.1 Coagulation Analyzers-Pipeline Products by Stage of Development 7
3.2 Coagulation Analyzers-Pipeline Products by Territory 8
3.3 Coagulation Analyzers-Pipeline Products by Regulatory Path 9
3.4 Coagulation Analyzers-Pipeline Products by Estimated Approval Date 10
4 Coagulation Analyzers-Pipeline Products under Development by Companies 11
4.1 Coagulation Analyzers Companies-Pipeline Products by Stage of Development 11
4.2 Coagulation Analyzers-Pipeline Products by Stage of Development 12
5 Coagulation Analyzers Companies and Product Overview 13
5.1 Analyticon Biotechnologies AG Company Overview 13
5.2 BioMedica USA LLC (Inactive) Company Overview 18
5.3 Braun Biosystems, Inc. Company Overview 19
5.4 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 20
5.5 Helena Laboratories Corp Company Overview 21
5.6 HemoSonics, LLC Company Overview 22
5.7 Nexus Medical, LLC Company Overview 29
5.8 SonoMedix, Inc. Company Overview 30
5.9 Universal Biosensors Inc Company Overview 31
5.10 University of Michigan Company Overview 32
5.11 University of Texas Health Science Center at Houston Company Overview 33
6 Coagulation Analyzers- Recent Developments 34
6.1 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 34
6.2 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 34
6.3 May 25, 2018: Groundbreaking POC hemostasis diagnostic to be presented at Major European Meetings 35
6.4 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends 36
6.5 May 25, 2018: Siemens appoints new CEO of Siemens Mexico, Central America, and Caribbean 38
6.6 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 38
6.7 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency 40
6.8 May 15, 2018: Proposed nominations of future Siemens Alstom Board of Directors completed 41
6.9 May 09, 2018: Siemens Announces Earnings Release and Financial Results Q2 FY 2018 42
6.10 May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 44
6.11 May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 46
6.12 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 49
6.13 May 07, 2018: Instrumentation Laboratory Worldwide Sales Top USD970 M In 2017 50
6.14 May 03, 2018: Siemens Healthineers fully on track to meet the targets 51
6.15 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales 52
6.16 May 01, 2018: Trinity Biotech announces Results for Q1, 2018 55
6.17 May 01, 2018: Predicting side effects before they happen 57
7 Appendix 117
7.1 Methodology 117
7.2 About GlobalData 120
7.3 Contact Us 120
7.4 Disclaimer 120
List of Figure
1.2 List of Figures
Figure 1: Coagulation Analyzers-Pipeline Products by Stage of Development 8
Figure 2: Coagulation Analyzers-Pipeline Products by Territory 9
Figure 3: Coagulation Analyzers-Pipeline Products by Regulatory Path 10
Figure 4: Coagulation Analyzers-Pipeline Products by Estimated Approval Date 11
List of Table
1.1 List of Tables
Table 1: Coagulation Analyzers-Pipeline Products by Stage of Development 8
Table 2: Coagulation Analyzers-Pipeline Products by Territory 9
Table 3: Coagulation Analyzers-Pipeline Products by Regulatory Path 10
Table 4: Coagulation Analyzers-Pipeline Products by Estimated Approval Date 11
Table 5: Coagulation Analyzers Companies-Pipeline Products by Stage of Development 12
Table 6: Coagulation Analyzers-Pipeline Products by Stage of Development 13
Table 7: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 14
Table 8: Coagulyzer 1-Product Status 14
Table 9: Coagulyzer 1-Product Description 15
Table 10: Coagulyzer 100-Product Status 15
Table 11: Coagulyzer 100-Product Description 16
Table 12: Coagulyzer 2-Product Status 16
Table 13: Coagulyzer 2-Product Description 17
Table 14: Coagulyzer 4-Product Status 17
Table 15: Coagulyzer 4-Product Description 18
Table 16: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: Portable Diagnostic System-Hemostasis-Product Status 19
Table 18: Portable Diagnostic System-Hemostasis-Product Description 19
Table 19: Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: Bio6-Product Status 20
Table 21: Bio6-Product Description 20
Table 22: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: Hemostasis Monitoring Microfluidic Device-Product Status 21
Table 24: Hemostasis Monitoring Microfluidic Device-Product Description 21
Table 25: Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 22
Table 26: Cascade Abrazo Analyzer-Product Status 22
Table 27: Cascade Abrazo Analyzer-Product Description 22
Table 28: HemoSonics, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 29: HemoSonics Global Hemostasis Analyzer-Chronic Liver Disease-Product Status 23
Table 30: HemoSonics Global Hemostasis Analyzer-Chronic Liver Disease-Product Description 24
Table 31: HemoSonics Global Hemostasis Analyzer-Intensive Care-Product Status 24
Table 32: HemoSonics Global Hemostasis Analyzer-Intensive Care-Product Description 24
Table 33: HemoSonics Global Hemostasis Analyzer-Neurosurgery-Product Status 25
Table 34: HemoSonics Global Hemostasis Analyzer-Neurosurgery-Product Description 25
Table 35: HemoSonics Global Hemostasis Analyzer-Oral Contraception-Product Status 25
Table 36: HemoSonics Global Hemostasis Analyzer-Oral Contraception-Product Description 26
Table 37: HemoSonics Global Hemostasis Analyzer-Orthopedic Surgery-Product Status 26
Table 38: HemoSonics Global Hemostasis Analyzer-Orthopedic Surgery-Product Description 26
Table 39: HemoSonics Global Hemostasis Analyzer-Perinatal Care-Product Status 27
Table 40: HemoSonics Global Hemostasis Analyzer-Perinatal Care-Product Description 27
Table 41: HemoSonics Global Hemostasis Analyzer-Trauma-Product Status 27
Table 42: HemoSonics Global Hemostasis Analyzer-Trauma-Product Description 28
Table 43: HemoSonics Global Hemostasis Analyzer HS-GHA-Product Status 28
Table 44: HemoSonics Global Hemostasis Analyzer HS-GHA-Product Description 28
Table 45: Quantra Hemostasis Analyzer-Product Status 29
Table 46: Quantra Hemostasis Analyzer-Product Description 29
Table 47: Nexus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 48: ProTime InRhythm-Product Status 30
Table 49: ProTime InRhythm-Product Description 30
Table 50: SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 51: NanoAcoustic Blood Analyzer-Product Status 31
Table 52: NanoAcoustic Blood Analyzer-Product Description 31
Table 53: Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 54: Handheld POC Coagulation Testing System-Ambulatory Care-Product Status 32
Table 55: Handheld POC Coagulation Testing System-Ambulatory Care-Product Description 32
Table 56: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 33
Table 57: mHemoRetractoMeter-Product Status 33
Table 58: mHemoRetractoMeter-Product Description 33
Table 59: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 34
Table 60: MEMS Based Blood Coagulometer-Product Status 34
Table 61: MEMS Based Blood Coagulometer-Product Description 34
Table 62: Glossary 120
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.